摘要
目的:协作标定首批冻干抗-HBs 国家标准品。方法:以首批抗-HBs 国际标准品(17—2—77批号)为标准,采用放射免疫法标定我国抗-HBs 国家标准品。结果:国家标准品(人免疫球蛋白)的效价为2.5 IU·支^(-1),抗-HBs 国家标准品(人血浆)的效价为1.3 IU·支^(-1)。将以上标准品按标示量加水溶解后于4℃放置9 d 和将冻干标准品分别置于4,23,45℃保存6个月,进行稳定性考察。研制的首批冻干抗-HBs 国家标准品稳定性良好,其他项目符合国家标准品要求。结论:已制备首批抗-HBs 国家标准品,并获得国家标准品批准文号。
Objective:To calibrate the 1^st national standard for anti -hepatitis B surface antigen (anti -HBs) by the collaborative study. Method:The potencies of the national standard for were assayed against 15, international standard for anti - hepatitis B immunoglobulin (lot : 17 - 2 - 77) by RIA method. The reconstituted solutions of anti -HBs national standards were stored at 4 ℃ for 9 days and the freeze -dry standards were stored at 4,23,45 ℃ for 6 months for stability studies. Results: The potency of anti - HBs ( human immunoglobulin) was 2.5 IU · per ampoule^-1 ;The potency of anti - HBs (human plasma) was 1.3 IU perampoule^-l. The results of stability studies showed that the preparation was very stable. The all other items met the requirements for national standard of China. Conclusion:The 1^st national standard for anti -HBs are established and are authorized.
出处
《药物分析杂志》
CAS
CSCD
北大核心
2008年第8期1307-1309,共3页
Chinese Journal of Pharmaceutical Analysis
关键词
抗-HBs国家标准品
人乙型肝炎免疫球蛋白
协作标定
national standard for anti - hepatitis B surface antigen ( anti - HBs )
human hepatitis B immunoglobulin
Collaborative study